MedTrace Logo

Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

NCT03897192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2019-04-01

No results posted yet for this study

Summary

To report the long term prognosis in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).

Conditions

  • Punctate Inner Choroidopathy

Interventions

DRUG

Bevacizumab

Anti-vascular endothelial growth factor (VEGF)

Sponsors & Collaborators

  • Changhua Christian Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-01-31
Completion
2019-03-20

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03897192 on ClinicalTrials.gov